BUSINESS HUTCHMED Reports 2026 Interim Results Thursday, July 30, 2026 · hutchmed (china) limited Source Summary — China product sales recovery continues led by ELUNATE ® and SULANDA ® with over 40% growth each — Advertisement Read Original Article → Related Dispatches [US] · Jul 30 Plume Earns Highest Honor with Three Gold Stevie® Awards for Technology Excellence in AI, Product and Leadership [US] · Jul 30 Continuity Biosciences Appoints Vicky Papoutsis to Board of Directors [US] · Jul 30 Spark Biomedical to Present Acute Stress Reaction, Anxiety, and Sleep Data at 2026 Military Health System Research Symposium